+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Gastrointestinal Drugs Global Market Report 2020-30: COVID-19 Implications and Growth

  • ID: 5028668
  • Report
  • May 2020
  • Region: Global
  • 300 pages
  • The Business Research Company

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Allergan Plc
  • AstraZeneca Plc
  • Johnson & Johnson
  • Novo Nordisk A/S
  • Takeda Pharmaceticals
Gastrointestinal Drugs Global Market Report 2020-30: COVID-19 Implications and Growth from the publisher covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for gastrointestinal drugs. Vitamins and Minerals play a crucial role in the treatment of pateints with COVID-19 as they are used as immunity boosters.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:
Where is the largest and fastest growing market for the gastrointestinal drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Gastrointestinal Drugs Market global report from the publisher answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider gastrointestinal drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The gastrointestinal drugs market section of the report gives context. It compares the gastrointestinal drugs market with other segments of the gastrointestinal drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, gastrointestinal drugs indicators comparison.
Scope

Markets Covered:
1) By Type: Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity; Antiemetics And Antinauseants; Antidiarrhoeals
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Takeda Pharmaceticals; Allergan Plc; Novo Nordisk A/S; AstraZeneca Plc; Johnson & Johnson

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, gastrointestinal drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan Plc
  • AstraZeneca Plc
  • Johnson & Johnson
  • Novo Nordisk A/S
  • Takeda Pharmaceticals
1. Executive Summary

2. Report Structure

3. Gastrointestinal Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Gastrointestinal Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Gastrointestinal Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Gastrointestinal Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Gastrointestinal Drugs Market Trends And Strategies

8. Gastrointestinal Drugs Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, Value ($ Billion)
8.2.1. Drivers Of The Market
8.2.2. Restraints On The Market
8.3. Forecast Market Growth, Value ($ Billion)
8.3.1. Drivers Of The Market
8.3.2. Restraints On The Market

9. Gastrointestinal Drugs Market Regional Analysis
9.1. Global Gastrointestinal Drugs Market, 2019, By Region, Value ($ Billion)
9.2. Global Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
9.3. Global Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Region

10. Gastrointestinal Drugs Market Segmentation
10.1. Global Gastrointestinal Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Antacids
  • Antiulcerants
  • Vitamin And Minerals
  • Antiobesity
  • Antiemetics And Antinauseants
  • Antidiarrhoeals
10.2. Global Gastrointestinal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
10.3. Global Gastrointestinal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Others
10.4. Global Gastrointestinal Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Branded Drugs
  • Generic Drugs
10.5. Global Gastrointestinal Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
11. Gastrointestinal Drugs Market Metrics
11.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, 2015-2023, Global
11.2. Per Capita Average Gastrointestinal Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Gastrointestinal Drugs Market
12.1. Asia-Pacific Gastrointestinal Drugs Market Overview
12.2. Asia-Pacific, Gastrointestinal Drugs Market, 2019, By Country, Value ($ Billion)
12.3. Asia-Pacific, Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
12.4. Asia-Pacific, Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
12.5. Asia-Pacific, Gastrointestinal Drugs Market Metrics
12.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2015-2023, Asia-Pacific Countries
12.6. Asia-Pacific Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7. Asia-Pacific Gastrointestinal Drugs Market: Country Analysis
12.7.1. China Gastrointestinal Drugs Market
12.7.1.1. China Gastrointestinal Drugs Market Overview
12.7.1.2. China Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.1.3. China Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.2. Australia Gastrointestinal Drugs Market
12.7.2.1. Australia Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.2.2. Australia Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.3. Hong Kong Gastrointestinal Drugs Market
12.7.3.1. Hong Kong Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.4. India Gastrointestinal Drugs Market
12.7.4.1. India Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.4.2. India Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.5. Indonesia Gastrointestinal Drugs Market
12.7.5.1. Indonesia Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.5.2. Indonesia Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.6. Japan Gastrointestinal Drugs Market
12.7.6.1. Japan Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.6.2. Japan Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.7. Malaysia Gastrointestinal Drugs Market
12.7.7.1. Malaysia Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.8. New Zealand Gastrointestinal Drugs Market
12.7.8.1. New Zealand Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.9. Philippines Gastrointestinal Drugs Market
12.7.9.1. Philippines Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.10. Singapore Gastrointestinal Drugs Market
12.7.10.1. Singapore Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.11. South Korea Gastrointestinal Drugs Market
12.7.11.1. South Korea Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.11.2. South Korea Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.12. Thailand Gastrointestinal Drugs Market
12.7.12.1. Thailand Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.13. Vietnam Gastrointestinal Drugs Market
12.7.13.1. Vietnam Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Gastrointestinal Drugs Market
13.1. Western Europe Gastrointestinal Drugs Market Overview
13.2. Western Europe, Gastrointestinal Drugs Market, 2019, By Country, Value ($ Billion)
13.3. Western Europe, Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
13.4. Western Europe, Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
13.5. Western Europe, Gastrointestinal Drugs Market Metrics
13.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2015-2023, Western Europe Countries
13.6. Western Europe Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7. Western Europe Gastrointestinal Drugs Market: Country Analysis
13.7.1. Austria Gastrointestinal Drugs Market
13.7.1.1. Austria Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.2. Belgium Gastrointestinal Drugs Market
13.7.2.1. Belgium Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.3. Denmark Gastrointestinal Drugs Market
13.7.3.1. Denmark Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.4. Finland Gastrointestinal Drugs Market
13.7.4.1. Finland Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5. France Gastrointestinal Drugs Market
13.7.5.1. France Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5.2. France Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6. Germany Gastrointestinal Drugs Market
13.7.6.1. Germany Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6.2. Germany Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.7. Ireland Gastrointestinal Drugs Market
13.7.7.1. Ireland Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.8. Italy Gastrointestinal Drugs Market
13.7.8.1. Italy Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.9. Netherlands Gastrointestinal Drugs Market
13.7.9.1. Netherlands Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.10. Norway Gastrointestinal Drugs Market
13.7.10.1. Norway Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.11. Portugal Gastrointestinal Drugs Market
13.7.11.1. Portugal Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.12. Spain Gastrointestinal Drugs Market
13.7.12.1. Spain Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.13. Sweden Gastrointestinal Drugs Market
13.7.13.1. Sweden Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.14. Switzerland Gastrointestinal Drugs Market
13.7.14.1. Switzerland Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.15. UK Gastrointestinal Drugs Market
13.7.15.1. UK Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.15.2. UK Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Gastrointestinal Drugs Market
14.1. Eastern Europe Gastrointestinal Drugs Market Overview
14.2. Eastern Europe, Gastrointestinal Drugs Market, 2019, By Country, Value ($ Billion)
14.3. Eastern Europe, Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
14.4. Eastern Europe, Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
14.5. Eastern Europe, Gastrointestinal Drugs Market Metrics
14.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2015-2023, Eastern Europe Countries
14.6. Eastern Europe Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7. Eastern Europe Gastrointestinal Drugs Market: Country Analysis
14.7.1. Czech Republic Gastrointestinal Drugs Market,
14.7.1.1. Czech Republic Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.2. Poland Gastrointestinal Drugs Market
14.7.2.1. Poland Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.3. Romania Gastrointestinal Drugs Market
14.7.3.1. Romania Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4. Russia Gastrointestinal Drugs Market
14.7.4.1. Russia Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4.2. Russia Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Gastrointestinal Drugs Market
15.1. North America Gastrointestinal Drugs Market Overview
15.2. North America, Gastrointestinal Drugs Market, 2019, By Country, Value ($ Billion)
15.3. North America, Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
15.4. North America, Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
15.5. North America, Gastrointestinal Drugs Market Metrics
15.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2015-2023, North America Countries
15.6. North America Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7. North America Gastrointestinal Drugs Market: Country Analysis
15.7.1. Canada Gastrointestinal Drugs Market
15.7.1.1. Canada Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.2. Mexico Gastrointestinal Drugs Market
15.7.2.1. Mexico Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3. USA Gastrointestinal Drugs Market
15.7.3.1. USA Gastrointestinal Drugs Market Overview
15.7.3.2. USA Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3.3. USA Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Gastrointestinal Drugs Market
16.1. South America Gastrointestinal Drugs Market Overview
16.2. South America, Gastrointestinal Drugs Market, 2019, By Country, Value ($ Billion)
16.3. South America, Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
16.4. South America, Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
16.5. South America, Gastrointestinal Drugs Market Metrics
16.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2015-2023, South America Countries
16.6. South America Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7. South America Gastrointestinal Drugs Market: Country Analysis
16.7.1. Argentina Gastrointestinal Drugs Market
16.7.1.1. Argentina Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2. Brazil Gastrointestinal Drugs Market
16.7.1.1. Brazil Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2.2. Brazil Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.3. Chile Gastrointestinal Drugs Market
16.7.3.1. Chile Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.4. Colombia Gastrointestinal Drugs Market
16.7.4.1. Colombia Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.5. Peru Gastrointestinal Drugs Market
16.7.5.1. Peru Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.6. Venezuela Gastrointestinal Drugs Market
16.7.6.1. Venezuela Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Gastrointestinal Drugs Market
17.1. Middle East Gastrointestinal Drugs Market Overview
17.2. Middle East, Gastrointestinal Drugs Market, 2019, By Country, Value ($ Billion)
17.3. Middle East, Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
17.4. Middle East, Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
17.5. Middle East, Gastrointestinal Drugs Market Metrics
17.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2015-2023, Middle East Countries
17.6. Middle East Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7. Middle East Gastrointestinal Drugs Market: Country Analysis
17.7.1. Saudi Arabia Gastrointestinal Drugs Market
17.7.1.1. Saudi Arabia Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.2. Israel Gastrointestinal Drugs Market
17.7.2.1. Israel Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.3. Turkey Gastrointestinal Drugs Market
17.7.3.1. Turkey Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.4. UAE Gastrointestinal Drugs Market
17.7.4.1. UAE Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Gastrointestinal Drugs Market
18.1. Africa Gastrointestinal Drugs Market Overview
18.2. Africa, Gastrointestinal Drugs Market, 2019, By Country, Value ($ Billion)
18.3. Africa, Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
18.4. Africa, Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
18.5. Africa, Gastrointestinal Drugs Market Metrics
18.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2015-2023, Africa Countries
18.6. Africa Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7. Africa Gastrointestinal Drugs Market: Country Analysis
18.7.1. Egypt Gastrointestinal Drugs Market
18.7.1.1. Egypt Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.2. Nigeria Gastrointestinal Drugs Market
18.7.2.1. Nigeria Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.3. South Africa Gastrointestinal Drugs Market
18.7.3.1. South Africa Gastrointestinal Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Gastrointestinal Drugs Market Competitive Landscape
19.1. Competitive Market Overview
19.2. Market Shares
19.3. Company Profiles
19.3.1. Takeda Pharmaceticals
19.3.1.1. Company Overview
19.3.1.2. Products And Services
19.3.1.3. Strategy
19.3.1.4. Financial Performance
19.3.2. Allergan Plc
19.3.2.1. Company Overview
19.3.2.2. Products And Services
19.3.2.3. Strategy
19.3.2.4. Financial Performance
19.3.3. Novo Nordisk A/S
19.3.3.1. Company Overview
19.3.3.2. Products And Services
19.3.3.3. Strategy
19.3.3.4. Financial Performance
19.3.4. AstraZeneca Plc
19.3.4.1. Company Overview
19.3.4.2. Products And Services
19.3.4.3. Strategy
19.3.4.4. Financial Performance
19.3.5. Johnson & Johnson
19.3.5.1. Company Overview
19.3.5.2. Products And Services
19.3.5.3. Strategy
19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market

21. Market Background: Pharmaceutical Drugs Market
21.1. Pharmaceutical Drugs Market Characteristics
21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations
22.1. Global Gastrointestinal Drugs Market In 2023- Growth Countries
22.2. Global Gastrointestinal Drugs Market In 2023- Growth Segments
22.3. Global Gastrointestinal Drugs Market In 2023- Growth Strategies

23. Appendix
23.1. NAICS Definitions Of Industry Covered In This Report
23.2. Abbreviations
23.3. Currencies
23.4. Research Inquiries
23.5. About the Publisher

24. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan Plc
  • AstraZeneca Plc
  • Johnson & Johnson
  • Novo Nordisk A/S
  • Takeda Pharmaceticals
North America was the largest region in the global gastrointestinal drugs market, accounting for 48% of the market in 2019. Asia Pacific was the second largest region accounting for 24% of the global gastrointestinal drugs market. Africa was the smallest region in the global gastrointestinal drugs market.

Drug manufacturing companies are offering tranexamic acid for the treatment of acute gastrointestinal bleeding. Tranexamic acid is a medication used to treat or prevent excessive blood loss from major trauma or surgery and is now finding applications for gastrointestinal diseases. Tranexamic acid reduces clot breakdown, thus reducing the duration and amount of bleeding. This reduces mortality rate (from 10% to 7.5%) and the probability of blood transfusion by about 30%. Major companies manufacturing tranexamic acid include Abbott Laboratories, Pfizer, GlaxoSmithKline and Bayer AG.

The gastrointestinal drugs market consists of sales of gastrointestinal drugs and related services by entities (organizations, sole traders and partnerships) that produce gastrointestinal drugs to treat gastrointestinal diseases. This industry includes establishments that produce drugs such as antacids to treat acid reflux, indigestion and others, antiulcerants drugs to treat intestinal ulcers, antiobesity drugs and antiemetics drugs. It also consists of establishments which produce essential nutrients such as vitamins and mineral supplements.

The global gastrointestinal drugs market is expected to grow from $42.8 billion in 2019 to $48.5 billion in 2020 at a compound annual growth rate (CAGR) of 13.4%. The growth is mainly due to the impact of COVID-19 on digestive system. The digestive system manifestations in patients with COVID-19 include poor appetite, nausea, vomiting, diarrhea, abnormal liver enzymes, abdominal pain, and gastrointestinal bleeding. Patients with pre-existing digestive diseases such as inflammatory bowel disease may complain about exacerbation of symptoms or disease activity. The market is then expected to stabilize and grow at a CAGR of 4% from 2021 and reach $55.4 billion in 2023.
Note: Product cover images may vary from those shown
  • Takeda Pharmaceticals
  • Allergan Plc
  • Novo Nordisk A/S
  • AstraZeneca Plc
  • Johnson & Johnson
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll